{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:20:07Z","timestamp":1773332407705,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,21]]},"DOI":"10.7759\/cureus.76148","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T21:18:05Z","timestamp":1734815885000},"source":"Crossref","is-referenced-by-count":2,"title":["The Feasibility of Omega-3 Supplementation Compared to Placebo in the Management of Long COVID Symptoms Among Healthcare Workers: A Randomized Controlled Trial"],"prefix":"10.7759","author":[{"given":"Arunima","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Speiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Dara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinwe","family":"Ogedegbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Portia","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Therese","family":"Estanbouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lora","family":"Kasselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Kligler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elli","family":"Gourna Paleoudis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Parulekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Long COVID basics. (2024). Accessed. July 11, 2020: https:\/\/www.cdc.gov\/covid\/long-term-effects\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effect...."},{"key":"ref2","unstructured":"Long COVID. lasting effects of COVID-19. (2020). Accessed: August 23, 2020: https:\/\/www.mayoclinic.org\/diseases-conditions\/coronavirus\/in-depth\/coronavirus-long-term-effects\/art-20490351."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001056","article-title":"Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey","volume":"9","author":"Philip KE","year":"2022","unstructured":"Philip KE, Buttery S, Williams P, et al.. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res. 2022, 9:e001056. 10.1136\/bmjresp-2021-001056","journal-title":"BMJ Open Respir Res"},{"key":"ref4","unstructured":"Clinical overview of long COVID. (2020). Accessed. July 12, 2020: https:\/\/www.cdc.gov\/covid\/hcp\/clinical-overview\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical...."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2478\/aopf-2019-0006","article-title":"Omega-3 polyunsaturated fatty acids of fish and their role in cancerous cell lines: a review of in-vitro studies","volume":"27","author":"Jameel F","year":"2019","unstructured":"Jameel F, Agarwal P, Arshad M, Serajuddin M. Omega-3 polyunsaturated fatty acids of fish and their role in cancerous cell lines: a review of in-vitro studies. Fish Aquat Life. 2019, 27:47-63. 10.2478\/aopf-2019-0006","journal-title":"Fish Aquat Life"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1607414","article-title":"The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease","volume":"131","author":"Nelson JR","year":"2019","unstructured":"Nelson JR, Raskin S. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease. Postgrad Med. 2019, 131:268-77. 10.1080\/00325481.2019.1607414","journal-title":"Postgrad Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2024.06.053","article-title":"Role of omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic (DHA) as modulatory and anti-inflammatory agents in noncommunicable diet-related diseases - reports from the last 10 years","volume":"63","author":"Banaszak M","year":"2024","unstructured":"Banaszak M, Dobrzy\u0144ska M, Kawka A, G\u00f3rna I, Wo\u017aniak D, Przys\u0142awski J, Drzyma\u0142a-Czy\u017c S. Role of omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic (DHA) as modulatory and anti-inflammatory agents in noncommunicable diet-related diseases - reports from the last 10 years. Clin Nutr ESPEN. 2024, 63:240-58. 10.1016\/j.clnesp.2024.06.053","journal-title":"Clin Nutr ESPEN"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2042991","article-title":"Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study","volume":"38","author":"Maamar M","year":"2022","unstructured":"Maamar M, Artime A, Pariente E, et al.. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022, 38:901-9. 10.1080\/03007995.2022.2042991","journal-title":"Curr Med Res Opin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2012.2815","article-title":"Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA)","volume":"10","author":"EFSA Panel on Dietetic Products","year":"2012","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J. 2012, 10:2815. 10.2903\/j.efsa.2012.2815","journal-title":"EFSA J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S357460","article-title":"Potential of omega 3 supplementation for coronavirus disease 2019 (COVID-19): a scoping review","volume":"15","author":"Nursyifa Fadiyah N","year":"2022","unstructured":"Nursyifa Fadiyah N, Megawati G, Erlangga Luftimas D. Potential of omega 3 supplementation for coronavirus disease 2019 (COVID-19): a scoping review. Int J Gen Med. 2022, 15:3915-22. 10.2147\/IJGM.S357460","journal-title":"Int J Gen Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02795-5","article-title":"The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial","volume":"19","author":"Doaei S","year":"2021","unstructured":"Doaei S, Gholami S, Rastgoo S, et al.. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial. J Transl Med. 2021, 19:128. 10.1186\/s12967-021-02795-5","journal-title":"J Transl Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12010028","article-title":"Effectiveness of omega-3 fatty acid supplementation in improving the metabolic and inflammatory profiles of Mexican adults hospitalized with COVID-19","volume":"12","author":"Rodr\u00edguez-Vera D","year":"2024","unstructured":"Rodr\u00edguez-Vera D, Salazar JR, Soriano-Urs\u00faa MA, et al.. Effectiveness of omega-3 fatty acid supplementation in improving the metabolic and inflammatory profiles of Mexican adults hospitalized with COVID-19. Diseases. 2024, 12:28. 10.3390\/diseases12010028","journal-title":"Diseases"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2022.11.011","article-title":"Association between blood N-3 fatty acid levels and the risk of coronavirus disease 2019 in the UK Biobank","volume":"117","author":"Harris WS","year":"2023","unstructured":"Harris WS, Tintle NL, Sathyanarayanan SP, Westra J. Association between blood N-3 fatty acid levels and the risk of coronavirus disease 2019 in the UK Biobank. Am J Clin Nutr. 2023, 117:357-63. 10.1016\/j.ajcnut.2022.11.011","journal-title":"Am J Clin Nutr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-010-0141-6","article-title":"The omega-3 index: clinical utility for therapeutic intervention","volume":"12","author":"Harris WS","year":"2010","unstructured":"Harris WS. The omega-3 index: clinical utility for therapeutic intervention. Curr Cardiol Rep. 2010, 12:503-8. 10.1007\/s11886-010-0141-6","journal-title":"Curr Cardiol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/318120-the-feasibility-of-omega-3-supplementation-compared-to-placebo-in-the-management-of-long-covid-symptoms-among-healthcare-workers-a-randomized-controlled-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T21:18:08Z","timestamp":1734815888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/318120-the-feasibility-of-omega-3-supplementation-compared-to-placebo-in-the-management-of-long-covid-symptoms-among-healthcare-workers-a-randomized-controlled-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.76148","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,21]]}}}